5/14
10:06 am
agio
Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress [Yahoo! Finance]
Low
Report
Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress [Yahoo! Finance]
5/14
10:00 am
agio
Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress
Low
Report
Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress
5/14
12:09 am
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
5/8
11:24 am
agio
Wall Street Analysts See a 26.01% Upside in Agios Pharmaceuticals (AGIO): Can the Stock Really Move This High? [Yahoo! Finance]
Low
Report
Wall Street Analysts See a 26.01% Upside in Agios Pharmaceuticals (AGIO): Can the Stock Really Move This High? [Yahoo! Finance]
5/6
07:00 am
agio
Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024
Medium
Report
Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024
5/5
08:29 am
agio
Earnings Beat: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts [Yahoo! Finance]
Medium
Report
Earnings Beat: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts [Yahoo! Finance]
5/3
02:04 pm
agio
Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates [Yahoo! Finance]
Low
Report
Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates [Yahoo! Finance]
5/3
01:33 pm
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $29.00 to $33.00. They now have a "neutral" rating on the stock.
Low
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $29.00 to $33.00. They now have a "neutral" rating on the stock.
5/3
11:23 am
agio
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/3
07:00 am
agio
Agios Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
Low
Report
Agios Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
5/3
07:00 am
agio
Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
Low
Report
Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
5/2
09:39 am
agio
Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]
Low
Report
Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]
5/2
07:13 am
agio
Agios Reports Business Highlights and First Quarter 2024 Financial Results [Yahoo! Finance]
Medium
Report
Agios Reports Business Highlights and First Quarter 2024 Financial Results [Yahoo! Finance]
5/2
07:00 am
agio
Agios Reports Business Highlights and First Quarter 2024 Financial Results
Medium
Report
Agios Reports Business Highlights and First Quarter 2024 Financial Results
4/18
07:00 am
agio
Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024
Low
Report
Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024
4/9
08:44 am
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Medium
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
4/9
07:15 am
agio
Agios Publishes 2024 Environmental, Social and Governance (ESG) Report [Yahoo! Finance]
Medium
Report
Agios Publishes 2024 Environmental, Social and Governance (ESG) Report [Yahoo! Finance]
4/9
07:00 am
agio
Agios Publishes 2024 Environmental, Social and Governance (ESG) Report
Medium
Report
Agios Publishes 2024 Environmental, Social and Governance (ESG) Report
3/30
09:56 am
agio
We Think Agios Pharmaceuticals (NASDAQ:AGIO) Can Afford To Drive Business Growth [Yahoo! Finance]
Low
Report
We Think Agios Pharmaceuticals (NASDAQ:AGIO) Can Afford To Drive Business Growth [Yahoo! Finance]
3/5
07:00 am
agio
Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024
Medium
Report
Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024
2/29
04:24 am
agio
Global PRMT5 Targeted Therapy Market & Clinical Trials Insights 2024: Innovation and Potential in Oncology and Beyond [Yahoo! Finance]
Medium
Report
Global PRMT5 Targeted Therapy Market & Clinical Trials Insights 2024: Innovation and Potential in Oncology and Beyond [Yahoo! Finance]
2/28
06:05 pm
agio
Global PRMT5 Targeted Therapy Market & Clinical Trials Opportunity Outlook 2024: PRMT5 Targeted Therapies Clinical Trials by Company, Indication & Phase [Yahoo! Finance]
Medium
Report
Global PRMT5 Targeted Therapy Market & Clinical Trials Opportunity Outlook 2024: PRMT5 Targeted Therapies Clinical Trials by Company, Indication & Phase [Yahoo! Finance]
2/23
01:09 pm
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target lowered by analysts at JPMorgan Chase & Co. from $31.00 to $30.00. They now have a "neutral" rating on the stock.
Low
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target lowered by analysts at JPMorgan Chase & Co. from $31.00 to $30.00. They now have a "neutral" rating on the stock.
2/22
07:00 am
agio
Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024
High
Report
Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024
2/20
08:38 am
agio
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]